XKH-31211-73019
2 vaccinations
3 coded responses
10 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 972 / OR
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Dose 1 — Pfizer-BioNTech
-
2021-04-21
Registered in v-safe
-
2021-04-21
Survey response — day 14, dose 1MedDRA: Acne cystic, Affective disorder, Cheilitis, Dehydration, Insomnia, Vulvovaginal dryness — Feeling: Good · Be unable to do your normal daily activitiesFree text: Vaginal dryness (which I never had up until this point), edginess, moodiness, trouble sleeping. Dehydration (that one may be due to the warm weather all of a sudden), cheilitis and cystic bacne.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Dose 2 — Pfizer-BioNTech
-
2021-04-24
Survey response — day 0, dose 2MedDRA: Heavy menstrual bleeding — Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesFree text: Related to heavy periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fever · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-07-24
- 2021-10-23
-
2022-04-24
Survey response — 12 months, dose 2MedDRA: Nasopharyngitis, Office visit — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Head cold · Healthcare visit (other): Prenatal appointmentMedDRA releases: 2024-11 · check-in free text available
-
2022-04-24
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2022-04-26
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-24 | Successful 2022-04-26 |
Not applicable - Accidental Reporting |
Free text
Release 7 — day 14, dose 1
Symptoms: Vaginal dryness (which I never had up until this point), edginess, moodiness, trouble sleeping. Dehydration (that one may be due to the warm weather all of a sudden), cheilitis and cystic bacne.
Release 7 — day 0, dose 2
Systemic reaction (other): Related to heavy period
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Acne cystic | ✓ | ✓ | ✓ |
| SD | Affective disorder | ✓ | ✓ | ✓ |
| SD | Cheilitis | ✓ | ✓ | ✓ |
| SD | Dehydration | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Vulvovaginal dryness | ✓ | ✓ | ✓ |
| SRO | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release